Denopamine, a selective β1-receptor agonist and a new coronary vasodilator

Current Medical Research and Opinion

Volumn 18, Issue 7, 2002, Pages 407-413

  Ishide, Takeshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1Adrenoceptors; Coronary vasodilation; Denopamine; Vasospastic angina pectoris

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DENOPAMINE; MAGNESIUM; NITRATE; PRAZOSIN; VASODILATOR AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; HUMAN; JAPAN; MALE; NONHUMAN; SYMPATHETIC NERVE; TREATMENT OUTCOME; VASODILATATION; VASOSPASM; CHEMISTRY; DRUG COMBINATION; MIDDLE AGED; REVIEW;

ADRENERGIC BETA-AGONISTS; AGED; ANGINA PECTORIS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; MIDDLE AGED;

EID: 0036025399     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001119     Document Type: Article

References (32)

1. Gersh BJ, Braunwald E, Bonow R. Chronic heart disease. In Braunwald E, Zipes DP, Libby P (Eds.): Heart Disease, WB Saunders Co., Philadelphia, 6th edn, pp.1272-352, 2001
2. Théroux P, Waters D. Diagnosis and management of patients with unstable angina. In Alexander RW, Schlant RC, Fuxter V (Eds): Hurst's Heart Disease, 9th Edn, McGraw-Hill, New York, pp.1307-47, 1998
3. Tzivoni D, Keren A, Benhorin J, Gottlieb S, Atlas D, Stern S. Prazosin therapy for refractory variant angina. Am Heart J 1983;105:262-6
4. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effects of magnesium on anginal attack induced by hyper-ventilation in patients with variant angina. Circulation 1989;79:597-602
5. Bugiardini R, Morgagni G, Pozzati A, Ottani F, Borghi A, Lenzi S, Puddu P. Effect of oral levodopa and carbidopa on coronary spasm in variant angina pectoris. Am J Cardiol 1987;60:689-93
6. Chiechia S, Patrono C, Crea F, Ciabattoni G, De Caterina R, Cinotti GA, Distante A, Maseri A. Effects of intravenous prostacyclin in variant angina. Circulation 1982;65:470-77
7. Rutitzky B, Girotti A, Rosenbaum MB. Efficacy of chronic amiodarone therapy in patients with variant angina pectoris and inhibition of ergonovine coronary constriction. Am Heart J 1982;103:38-43
8. Frenneaus M, Kaski JC, Brown M, Maseri A. Refractory variant angina relieved by guanethidine and clonidine. Am J Cardiol 1988;62:832-3
9. Murakami T, Mizuno S, Ohsato K, Moriuchi I, Arai Y, Nio Y, Kaku B, Takahashi Y, Ohnaka M. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus. Am J Cardiol 1999;84:92-4
10. Nagao T, Ikeo T, Murata S, Sato M, Nakajima H. Cardiovascular effects of a new-positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-2((3,4-dimethoxyphenetyl)-amino)-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart. Jpn J Pharmacol 1984;35:415-23
11. Nagao T, Nakajima H. Denopamine. Cardiovascular Drug Reviews 1989;7:310-25
12. 1-receptors. J Cardiovasc Pharmacol 1988;12:323-31
13. Aikawa J, Moroi M, Namiki A, Yamaguchi T, Machii K, Koike K, Takayanagi I. Vascular relaxing mechanism of denopamine in isolated canine coronary, femoral, mesenteric and renal arteries. Heart Vessels 1993;8:176-80
14. Shimizu H, Lee JD, Ogawa K, Sugiyama T, Yamamoto M, Hara A, Nakamura T. Refractory variant angina relieved by denopamine - A case report. Jpn Circ J, 1991;55:692-4
15. Yago T, Tashiro A, Shibata M, Suzuki T, Aoki H, Nakai K, Suzuki T, Hiramori K. A case of refractory vasospastic angina relieved by denopamine (in Japanese). Shinzou 2000;32:879-83
16. Komatsu T, Yomogida K, Katou T, Tunoda S. A case of refractory variant angina relieved by oral cardiotonic agent (denopamine) (in Japanese). Coronary 1994;11:259-64
17. Inoue M, Miyazawa Y, Iguchi N, Kasahara N, Kodama A, Haruta S, Kato J, Hirosawa K, Hosoda S. Refractory vasospastic angina relieved by denopamine (in Japanese). Ko to Jun 1994;42:387-91
18. Shimizu H, Lee JD, Ogawa K, Kato T, Shimizu K, M, Sugiyama T, Hara A, Nakamura T. Efficacy of denopamine in preventing anginal attacks due to coronary spasm (in Japanese). Cardioangiology 1991;29:418-21
19. Cohen RA, Shepherd JT, Vanhoutte PM. Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries. Circ Res 1983;52:16-25
20. Murray PA, Vatner SF. Carotid sinus baroreceptor control of right coronary circulation in normal, hypertrophied, and failing right ventricle of conscious dog. Circ Res 1981;49:1339-49
21. Schwaltz PJ, Stone HL. Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res 1977;41:51-8
22. Mohman DE, Feigl EO. Competition between sympathetic and metabolic vasodilation in the canine coronary circulation. Circ Res 1978;42:79-86
23. Johansen UJ, Mark AL, Marcus ML. Responsiveness to cardiac sympathetic nerve stimulation during maximal coronary dilation produced by adenosine. Circ Res 1982;50:510-17
24. Ricci DR, Orlick AE, Cipriano PR, Guthaner DF, Harrison DC. Altered adrenergic activity in coronary artery spasm: Insight into mechanisms based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol 1979;43:1073-9
25. Vatner SF, Hintze TH, Macho P. Regulation of large coronary arteries by β-adrenergic mechanisms in the conscious dog. Circ Res 1982;51:56-66
26. Vatner DE, Knight DR, Homcy CJ, Vatner SF, Young MA. Subtypes of β-adrenergic receptors in bovine coronary arteries. Circ Res 1986;59:463-73
27. Molenaar P, Jones CR, McMartin LR, Summers RJ. Autoradiographic localization and densitometric analysis of beta-1 and beta-2 adrenoceptors in the canine left anterior descending coronary artery. J Pharmacol Expl Ther 1988;246:387-93
28. Murphree SS, Saffitz JE. Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 1988;246:387-93
29. Feigl EO. Neural control of coronary blood flow. J Vasc Res 1988;35:85-92
30. Sugiyama S, Hanaki Y, Hayashi K, Ozawa T. Effects of denopamine on rat myocardium in comparison with isoprenaline. Arzneim Forsch 1989;39:1417-20
31. Crea F, Davies G, Romeo F, Chierchia S, Bugiardini R, Kaski JC, Freedman B, Maseri A. Myocardial ischemia during ergonovine testing: Different susceptibility to coronary vasoconstriction in patients with exertional and variant angina. Circulation 1984;69:690-95
32. Masseri A, Chierchia S, Kaski JC. Mixed angina pectoris. Am J Cardiol 1985;56:30E-33E